GSK inks multi-target pact with Engitix; Sangamo considers strategic optionsnews2026-06-08T14:17:48+00:00June 8th, 2026|Endpoints News|
Tango plans Phase 3 pancreatic cancer study after combo successnews2026-06-08T14:07:54+00:00June 8th, 2026|Endpoints News|
Biopharma’s top-paid CEOs of 2025: 25 making $25M+ news2026-06-08T14:00:45+00:00June 8th, 2026|Endpoints News|
Cavalry Biosciences pursues $75M Series B to test eye and muscle disorder drugsnews2026-06-08T13:52:14+00:00June 8th, 2026|Endpoints News|
What kind of damage has RFK Jr’s health department inflicted on vaccine research in the US so far?news2026-06-08T13:46:00+00:00June 8th, 2026|Chemistry World|
#ADA26: Novo Nordisk targets 2030 launch for triple-G obesity shotnews2026-06-08T13:17:32+00:00June 8th, 2026|Endpoints News|
